All News

Among patients who held ice in their mouth before, during and after chemotherapy, 78% did not experience oral mucositis.

Finding humor in cancer has helped me cope.

Erleada showed promising results in patients with metastatic castration-sensitive prostate cancer when compared with Xtandi and Zytiga.

A dose reduction of Erleada may result in fewer skin-related side effects for men with advanced prostate cancer — but only for those with a smaller body size, research showed.

Men with metastatic hormone-sensitive prostate cancer treated with Nubeqa, androgen-deprivation therapy and docetaxel had reductions in PSA levels that were associated with improved overall survival and a prolonged time to PSA progression.

May is National Melanoma and Skin Cancer Awareness Month, so we took a look at some of the top stories about the disease from 2023.

Even though my children are grown up, I still worry about their health — especially when it comes to breast cancer.

Extended-duration Nubeqa reduced the risk of death in patients with nonmetastatic castration-resistant prostate cancer, study results showed.

Patients with metastatic castration-resistant prostate cancer treated with radioligand therapy, a form of targeted therapy, had improvements in PSA levels and survival with favorable side effect profiles.

Dr. Naveen Pemmaraju outlines three reasons why he feels that there is “a momentum that’s unmistakable,” in the field of myeloproliferative neoplasms.

An interview with Kerry O’Neil, B.S.N., RN, OCN, finalist for the 2023 Extraordinary Healer® award.

In her 40 years as an oncology nurse and supervisor, Kerry O’Neil, B.S.N., RN, OCN, has eased the way for thousands of patients with cancer and their families

Watch Dr. Brandon J Blue, Dr. Surbhi Sidana, Dr. Kenneth H. Shain and Mary Derome answer questions about the future of treatment during the CURE Educated Patient Multiple Myeloma Summit.

An interview with Abbey Kaler, M.S., APRN, FNP-C, CMSRN, winner of the 2023 Extraordinary Healer® award.

Oncology nurse, Abbey Kaler, M.S., APRN, FNP-C, CMSRN daily follows the motto “Love, Listen and Heal.”

People are functioning as if the threat of COVID-19 is gone, but that’s not the case for many people with cancer.

From talk show host Jerry Springer’s death to “The Young and the Restless” star announcing a cancer diagnosis, here is what’s happening in the oncology space this week.

Watch Dr. Kenneth H. Shain, from Moffitt Cancer Center, discuss the future of myeloma treatment, including BiTE therapy, during the CURE Educated Patient Multiple Myeloma Summit.

A team from Rutgers University has figured out the science behind once-dormant, self-reviving cells, and the discovery may help predict which patients will experience relapse.

Patients with myeloma who are being treated with Tecvayli must discuss symptoms of cytokine release syndrome with their providers as soon as they happen.

Even though I’ve had no evidence of cancer for the last five years, I still stay up to date about the latest developments for the disease.

Advanced care planning should be an ongoing discussion, explained an oncology nurse.

CURE® welcomed over 500 attendees in person and hundreds virtually during the hybrid Extraordinary Healer® event.

Watch Dr. Surbhi Sidana, from Stanford Medicine, discuss CAR-T cell therapy during the CURE Educated Patient Multiple Myeloma Summit.

At first I was skeptical about how meditation and breathing techniques could help me with fear of cancer recurrence. But once I started practicing, I noticed a difference in my anxiety.

Researchers have found that nothing beats direct attention from a care provider to inspire exercise among young women who have been recently diagnosed with breast cancer.

A cancer diagnosis often means putting your life in the hands of people you hardly know.

Tislelizumab was found to improve overall survival among patients with advanced unresectable or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma.

Watch Dr. Brandon J Blue, Dr. Dickran Kazandjian and Dr. Marc J. Braunstein answer questions about disease management during the CURE Educated Patient Multiple Myeloma Summit.

I was surprised and saddened at how some of my friends were not there for me when I was undergoing cancer treatment. The oncology ward became a lonely place.